Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease

Journal of the American Society of Nephrology

Volumn 18, Issue 12, 2007, Pages 3078-3088

  Johnson, Tim S ^a,d   Fisher, Marie ^a   Haylor, John L ^a   Hau, Zoe ^a   Skill, N James ^a,b   Jones, Richard ^b   Saint, Robert ^b   Coutts, Ian ^b   Vickers, Melissa E ^a   El Nahas, A Meguid ^a   Griffin, Martin ^c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

^c ASTON UNIVERSITY   (United Kingdom)

^d NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYL 2 [(OXOPROPYL)THIO]IMIDAZOLIUM; COLLAGEN TYPE 1; COLLAGEN TYPE 3; N BENZYLOXYCARBONYL PHENYLALANYL 6 DIMETHYL SULFONIUM 5 OXO NORLEUCINE; NTU 281; NTU 283; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS LINKING; DISEASE COURSE; DRUG INHIBITION; DRUG MECHANISM; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; KIDNEY FIBROSIS; KIDNEY FUNCTION; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

EID: 36849037032     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006070690     Document Type: Article

References (37)

1. Lorand L, Conrad SM: Transglutaminases. Mol Cell Biochem 58: 9-35, 1984
2. Griffin M, Smith LL, Wynne J: Changes in transglutaminase activity in an experimental model of pulmonary fibrosis induced by paraquat. Br J Exp Pathol 60: 653-661, 1979
3. Mirza A, Liu SL, Frizell E, Zhu J, Maddukuri S, Martinez J, Davies P, Schwarting R, Norton P, Zern MA: A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB. Am J Physiol 272: G281-G288, 1997
4. Small K, Feng JF, Lorenz J, Donnelly ET, Yu A, Im MJ, Dorn GW, 2nd, Liggett SB: Cardiac specific overexpression of transglutaminase II (G(H)) results in a unique hypertrophy phenotype independent of phospholipase C activation. J Biol Chem 274: 21291-21296, 1999
5. Bowness JM, Venditti M, Tarr AH, Taylor JR: Increase in epsilon-(gamma-glutamyl)lysine crosslinks in atherosclerotic aortas. Atherosclerosis 111: 247-253, 1994
6. Johnson TS, El-Koraie AF, Skill NJ, Baddour NM, El Nahas AM, Njloma M, Adam AG, Griffin M: Tissue transglutaminase and the progression of human renal scarring. J Am Soc Nephrol 14: 2052-2062, 2003
7. Johnson TS, Griffin M, Thomas GL, Skill J, Cox A, Yang B, Nicholas B, Birckbichler PJ, Muchaneta-Kubara C, Meguid El Nahas A: The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. J Clin Invest 99: 2950-2960, 1997
8. Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH: Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16: 180-188, 2005
9. Johnson TS, Skill NJ, EI Nahas AM, Oldroyd SD, Thomas GL, Douthwaite JA, Haylor JL, Griffin M: Transglutaminase transcription and antigen translocation in experimental renal scarring. J Am Soc Nephrol 10: 2146-2157, 1999
10. Smethurst PA, Griffin M: Measurement of tissue transglutaminase activity in a permeabilized cell system: Its regulation by Ca2+ and nucleotides. Biochem J 313: 803-808, 1996
11. Kleman JP, Aeschlimann D, Paulsson M, van der Rest M: Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells. Biochemistry 34: 13768-13775, 1995
12. Aeschlimann D, Paulsson M: Cross-linking of laminin-nidogen complexes by tissue transglutaminase: A novel mechanism for basement membrane stabilization. J Biol Chem, 266: 15308-15317, 1991
13. Johnson TS, Scholfield CI, Parry J, Griffin M: Induction of tissue transglutaminase by dexamethasone: Its correlation to receptor number and transglutaminase-mediated cell death in a series of malignant hamster fibrosarcomas. Biochem J 331: 105-112, 1998
14. Verderio E, Nicholas B, Gross S, Griffin M: Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: Effects on the processing of fibronectin, cell attachment, and cell death. Exp Cell Res, 239: 119-138, 1998
15. Knight RL, Hand D, Piacentini M, Griffin M: Characterization of the transglutaminase-mediated large molecular weight polymer from rat liver: Its relationship to apoptosis. Eur J Cell Biol 60: 210-216, 1993
16. Thomas GL, Yang B, Wagner BE, Savill J, El Nahas AM: Cellular apoptosis and proliferation in experimental renal fibrosis. Nephrol Dial Transplant 13: 2216-2226, 1998
17. Nunes I, Gleizes PE, Metz CN, Rifkin DB: Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol 136: 1151-1163, 1997
18. Verderio E, Gaudry C, Gross S, Smith C, Downes S, Griffin M: Regulation of cell surface tissue transglutaminase: Effects on matrix storage of latent transforming growth factor-beta binding protein-1. J Histochem Cytochem 47: 1417-1432, 1999
19. Douthwaite JA, Johnson TS, Haylor JL, Watson P, El Nahas AM: Effects of transforming growth factor-betal on renal extracellular matrix components and their regulating proteins. J Am Soc Nephrol 10: 2109-2119, 1999
20. George MD, Vollberg TM, Floyd EE, Stein JP, Jetten AM: Regulation of transglutaminase type II by transforming growth factor-beta 1 in normal and transformed human epidermal keratinocytes. J Biol Chem 265: 11098-11104, 1990
21. Akimov SS, Belkin AM: Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: A role in TGFbeta-dependent matrix deposition. J Cell Sci 114: 2989-3000, 2001
22. Baldwin JJ, Remy DC, Claremon DA, United States Patent 5098707, filed 29 March 1991, published 24 March 1992
23. Fround KF, Doshi K, Gaul S: Transglutaminase inhibition by 2-[(2-oxopropyl) 10] imidazolium derivatives: Mechanism of factor Illa inactivation. Biochemistry 33: 10109-10119, 1994
24. Baumgartner W, Golenhofen N, Weth A, Hiiragi T, Saint R, Griffin M, Drenckhahn D: Role of transglutaminase 1 in stabilisation of intercellular junctions of the vascular endothelium. Histochem Cell Biol 122: 17-25, 2004
25. Skill NJ, Johnson TS, Courts IG, Saint RE, Fisher M, Huang L, El Nahas AM, Collighan RJ, Griffin M: Inhibition of transglutaminase activity reduces extracellular matrix accumulation induced by high glucose levels in proximal tubular epithelial cells. J Biol Chem 279: 47754-47762, 2004
26. Jones RA, Kotsakis P, Johnson TS, Chau D, Ali S, Melino G, Griffin M: Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death Differ 13: 1442-1453, 2006
27. Gross SR, Balklava Z, Griffin M: Importance of tissue transglutaminase in repair of extracellular matrices and cell death of dermal fibroblasts after exposure to a solarium ultraviolet A source. J Invest Dermatol 121: 412-423, 2003
28. Griffin M, Courts IG, Saint R: Novel Compounds and Methods of Using the Same. International Publication Number WO 2004/113363. GB patent PCT/GB2004/002569, 2004
29. Border WA, Noble NA: TGF-beta in kidney fibrosis: A target for gene therapy. Kidney Int 51: 1388-1396, 1997
30. Cordella-Miele E, Miele L, Mukherjee AB: A novel transglutaminase- mediated post-translational modification of phospholipase A2 dramatically increases its catalytic activity. J Biol Chem 265: 17180-17188, 1990
31. Miele L: New weapons against inflammation: Dual inhibitors of phospholipase A2 and transglutaminase. J Clin Invest 111: 19-21, 2003
32. Lorand L, Graham RM: Transglutaminases: Crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4: 140-156, 2003
33. Verderio EA, Johnson TS, Griffin M: Transglutaminases in wound healing and inflammation. Prog Exp Tumor Res 38: 89-114, 2005
34. Oldroyd SD, Thomas GL, Gabbiani G, El Nahas AM: Interferon-gamma inhibits experimental renal fibrosis. Kidney Int 56: 2116-2127, 1999
35. Griffin M, Wilson J: Detection of epsilon(gamma-glutamyl) lysine. Mol Cell Biochem 58: 37-49, 1984
36. Johnson TS, Haylor JL, Thomas GL, Fisher M, El Nahas AM: Matrix metalloproteinases and their inhibitions in experimental renal scarring. Exp Nephrol 10: 182-195, 2002
37. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB: An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 216: 276-284, 1994